These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2925274)

  • 1. Amplification of c-ras-Ki oncogene in human ovarian tumours.
    Boltz EM; Kefford RF; Leary JA; Houghton CR; Friedlander ML
    Int J Cancer; 1989 Mar; 43(3):428-30. PubMed ID: 2925274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of cellular oncogene rearrangement or amplification in ovarian adenocarcinomas.
    Smith DM; Groff DE; Pokul RK; Bear JL; Delgado G
    Am J Obstet Gynecol; 1989 Oct; 161(4):911-5. PubMed ID: 2801838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay.
    Fukumoto M; Estensen RD; Sha L; Oakley GJ; Twiggs LB; Adcock LL; Carson LF; Roninson IB
    Cancer Res; 1989 Apr; 49(7):1693-7. PubMed ID: 2647292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of c-K-ras amplification during progression in a patient with adenocarcinoma of the ovary.
    Filmus JE; Buick RN
    Cancer Res; 1985 Sep; 45(9):4468-72. PubMed ID: 4028028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene patterns in breast and ovarian carcinomas.
    Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
    Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of amplifications of myc gene (c-myc and N-myc) in human ovarian cancer].
    Kataoka A; Yakushiji M; Kojiro M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Mar; 42(3):259-63. PubMed ID: 2332674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification and expression of c-Ki-ras oncogene in human ovarian cancer.
    Chien CH; Chang KT; Chow SN
    Proc Natl Sci Counc Repub China B; 1990 Jan; 14(1):27-32. PubMed ID: 1696386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amplification of proto-oncogenes C-myc, C-N-ras, C-Ki-ras, C-erbB2 in ovarian carcinoma].
    Bian M; Fan Q; Huang S
    Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):406-9. PubMed ID: 7587576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amplification of c-myc proto-oncogene in primary tumors, metastases and blood leukocytes of patients with ovarian cancer].
    Serova OM
    Eksp Onkol; 1987; 9(1):25-7. PubMed ID: 3028756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplifications of proto-oncogenes in ovarian carcinoma.
    Bian M; Fan Q; Huang S; Ma J; Lang J
    Chin Med J (Engl); 1995 Nov; 108(11):844-8. PubMed ID: 8585978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The amplification of c-myc, N-ras, c-erb B oncogenes in ovarian malignancies].
    Xin XY
    Zhonghua Fu Chan Ke Za Zhi; 1993 Jul; 28(7):405-7, 442. PubMed ID: 8287725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours.
    Courjal F; Cuny M; Rodriguez C; Louason G; Speiser P; Katsaros D; Tanner MM; Zeillinger R; Theillet C
    Br J Cancer; 1996 Dec; 74(12):1984-9. PubMed ID: 8980401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unique pattern of proto-oncogene abnormalities in ovarian adenocarcinomas.
    Zhou DJ; Gonzalez-Cadavid N; Ahuja H; Battifora H; Moore GE; Cline MJ
    Cancer; 1988 Oct; 62(8):1573-6. PubMed ID: 3167770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-myc amplification in ovarian cancer.
    Baker VV; Borst MP; Dixon D; Hatch KD; Shingleton HM; Miller D
    Gynecol Oncol; 1990 Sep; 38(3):340-2. PubMed ID: 2227545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ZNF217 gene was detected in ovarian serous cystadenocarcinoma by fluorescence in situ hybridization].
    Zhong M; Li J; Ding YQ; Song LL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):665-7. PubMed ID: 17160949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relation between prognosis and amplification of the c-erB-2 (HER-2/neu) proto-oncogene in ovarian carcinomas].
    Fan QB; Bian ML; Huang SZ
    Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):683-5, 710. PubMed ID: 7866905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification and rearrangement of the Kirsten ras oncogene in virus-transformed BALB/c 3T3 cells during malignant tumor progression.
    Radinsky R; Kraemer PM; Raines MA; Kung HJ; Culp LA
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5143-7. PubMed ID: 3474646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ras oncogene activation in human ovarian carcinoma.
    van 't Veer LJ; Hermens R; van den Berg-Bakker LA; Cheng NC; Fleuren GJ; Bos JL; Cleton FJ; Schrier PI
    Oncogene; 1988 Feb; 2(2):157-65. PubMed ID: 3285294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of oncogenes in metastatic tumours of human gastric carcinomas.
    Tsujino T; Yoshida K; Nakayama H; Ito H; Shimosato T; Tahara E
    Br J Cancer; 1990 Aug; 62(2):226-30. PubMed ID: 2386738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential.
    Haas CJ; Diebold J; Hirschmann A; Rohrbach H; Löhrs U
    Virchows Arch; 1999 Feb; 434(2):117-20. PubMed ID: 10071245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.